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Abstract
Background:  The  transverse  abdominal  plan  blockade  is  a  block  of  abdominal  wall  that  has  diff-
used rapidly  in  the  clinical  practice  as  part  of  a  multimodal  analgesia  for  abdominal  surgery.
The performance  of  the  ultrasound-guided  technique  has  allowed  the  lowering  of  potential
complications,  as  well  as  new  approaches  that  were  carried  out  according  to  the  descrip-
tions, and  the  prospective  studies  would  make  it  possible  to  utilize  the  transverse  abdominal
plan blockade  in  different  surgical  interventions;  however,  the  results  obtained  in  randomized
clinical  trials  are  inconsistent.
Objectives:  To  prepare  a  systematic  review  aiming  to  determine  the  efﬁcacy  of  the  ultrasound-
guided transverse  abdominal  plan  blockade  for  different  surgical  interventions,  as  well  as  the
indications  according  to  the  approaches  and  their  inﬂuences.
Methods:  Two  research  approaches,  one  manual,  and  the  other  in  Pubmed  returned  28  ran-
domized clinical  trials  where  intervention  with  ultrasound-guided  transverse  abdominal  plan
blockades was  performed  to  compare  the  analgesic  efﬁcacy  in  contrast  to  another  technique  in
adults, published  between  2007  and  October  2013,  in  English  or  Spanish,  with  Jadad  score  >  1,
according  to  the  inclusion  criteria  for  this  review.  The  authors  analyzed  independently  all  the
randomized  clinical  trials.
Conclusions:  The  transverse  abdominal  plan  blockades  have  been  shown  to  be  an  effective  tech-
nique in  colorectal  surgery,  cesarean  section,  cholecystectomy,  hysterectomy,  appendectomy,
donor nephrectomy,  retropubic  prostatectomy,  and  bariatric  surgery.  However,  the  data  found
in randomized  clinical  trial  are  not  conclusive,  and  as  a  result,  it  is  necessary  to  develop  new
and well  designed  randomized  clinical  trial,  with  enough  statistical  power  to  compare  different
approaches,  drugs,  doses,  and  volumes  for  the  same  intervention,  aiming  to  answer  the  current in  the  habitual  clinical  practice.
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PALAVRAS-CHAVE
Bloqueio  TAP;
Plano  transverso  do
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Ecoguiada;
Revisão  sistemática
Eﬁcácia  analgésica  do  bloqueio  ecoguiado  do  plano  transverso  do  abdome  --  revisão
sistemática
Resumo
Justiﬁcativa:  O  bloqueio  do  plano  transverso  abdominal  (TAP)  é  um  bloqueio  da  parede  abdom-
inal que  se  difundiu  rapidamente  na  prática  clínica  como  parte  de  analgesia  multimodal  em
cirurgia abdominal.  A  técnica  ecoguiada  permitiu  reduzir  as  possíveis  complicac¸ões,  assim  como
as novas  abordagens,  que,  de  acordo  com  as  descric¸ões  feitas  e  os  estudos  prospectivos,  per-
mitiram usar  o  TAP  em  vários  procedimentos  cirúrgicos;  no  entanto,  os  resultados  obtidos  em
ensaios clínicos  randomizados  (ECR)  são  inconsistentes.
Objetivos:  Revisão  sistemática  para  determinar  a  eﬁcácia  analgésica  do  TAP  ecoguiado  em
diversos procedimentos  cirúrgicos,  assim  como  determinar  as  indicac¸ões  de  acordo  com  abor-
dagens e  sua  inﬂuência.
Métodos:  Foi  feita  uma  pesquisa  no  PubMed  e  outra  livre  e  foram  encontrados  28  ECR  em  que
intervenc¸ão com  o  TAP  ecoguiado  era  feita  e  se  comparava  sua  eﬁcácia  analgésica  com  outra
técnica em  humanos  adultos,  publicados  entre  2007  e  outubro  de  2013  com  escore  de  Jadad
> 1,  em  inglês  ou  espanhol,  de  acordo  com  os  critérios  de  inclusão  para  esta  revisão.  Todos  os
ECR foram  analisados  de  forma  independente  pelos  autores.
Conclusões:  O  TAP  mostrou  ser  uma  técnica  eﬁcaz  em  cirurgia  colorretal,  cesárea,  colecistec-
tomia, histerectomia,  apendicectomia,  nefrectomia  em  doador,  prostatectomia  retropúbica  e
cirurgia bariátrica.  No  entanto,  os  dados  encontrados  nos  ECR  são  inconclusivos,  de  modo  que
mais ECR  bem  desenhados  são  necessários  e  com  poder  estatístico  suﬁciente  na  comparac¸ão  de
diferentes  abordagens,  drogas,  doses  e  volumes  para  uma  mesma  intervenc¸ão,  a  ﬁm  de  resolver
os temas  da  atualidade  e  seu  impacto  na  prática  clínica  habitual.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os
direitos reservados.
I
T
ﬁ
a
i
t
g
t
b
a
t
t
c
t
b
o
o
w
c
u
t
t
g
T
t
v
o
t
T
T
g
w
e
T
b
o
a
e
s
t
i
t
b
a
a
t
l
b
w
r
g
a
i
u
introduction
he  block  of  the  transversus  abdominis  plane  (TAP)  had  been
rst  described  as  a  block  of  the  abdominal  wall  based  on
natomical  references  to  introduce  local  anesthetic  (LA)
n  the  TAP  through  the  Petit  triangle  by  loss  of  resistance
echnique.1 In  2007  the  ﬁrst  description  of  the  ultrasound-
uided  TAP  appeared,2 and  its  use  has  become  popular  since
hen  in  high  and  low  abdominal  surgeries,  although  it  has  not
een  fully  integrated  in  the  regular  clinical  practice.3 The
pparition  of  the  ultrasound-guided  technique  has  allowed
he  reduction  of  block  failure  risk,  unacceptably  high  in
he  anatomical  technique4 as  well  as  reduction  of  possible
omplications  associated  with  this  technique5 even  though
hey  have  been  described6 but  probably  underestimated
ecause  of  publication  bias.
The  use  of  ultrasonography  has  allowed  the  development
f  new  approaches,  like  the  subcostal,  the  posterior,7 the
blique  subcostal,8 or  combinations  like  the  dual  TAP9 in
hich  the  possibilities  of  TAP  have  been  increased.  However,
urrently  there  is  no  recommendation  for  the  use  of  the
ltrasound-guided  TAP  in  comparison  to  the  classic  TAP10 due
o  a  lack  of  randomized  clinical  trials  (RCTs)  that  test  both
echniques.11
Potentially,  the  injection  of  LA  at  this  level  provides  anal-
esia  in  the  skin,  muscles  and  parietal  peritoneum  from
7  to  L1,  once  it  blocks  the  afferent  neuronal  endings  of
he  abdominal  walls.  However,  currently  there  is  a  contro-
ersy  in  the  specialized  literature  in  relation  to  the  level
f  distribution  of  the  local  anesthetic  with  a  single  injec-
ion,  since  some  studies  demonstrate  an  extension  from
t
a
g7  to  L112 and  others,  an  extension  from  T10  to  L1.13
he  greatest  extension  demonstrated  with  the  ultrasound-
uided  technique  is  T7  with  oblique  subcostal  TAP,  T9
ith  the  classic  mid-axillary  approach,  and  paravertebral
xtension  from  T4  to  L1  with  the  posterior  approach.14
hereby,  the  mid-axillary  TAP  should  be  used  for  infraum-
ilical  surgeries,  the  subcostal  for  periumbilical,  and  the
blique  subcostal  in  supraumbilical  incisions  between  T7
nd  T9.15 In  fact,  the  RCTs  are  poorly  correlated  to  the
xpected  extension  and  not  always  conclusive.  Considering
tudies  of  contrast  distribution15 it  is  possible  to  suppose
hat  the  diffusion  of  the  injected  substance  will  vary  accord-
ng  to  the  approach,  with  different  results  that  may  affect
he  analgesia.  The  current  literature  shows  that  not  all  the
lockades  are  equal,  and  that  the  approach  signiﬁcantly
lters  the  blockade’s  pharmacodynamics  and  the  resultant
nalgesia  characteristics.  Currently,  it  is  recognized  that
he  more  posterior  approaches,  in  other  words,  the  instal-
ation  of  the  needle  closer  to  the  traditional  approach,
ased  on  non-ultrasound-guided  original,  gives  rise  to  a
ider  analgesia  in  terms  of  dermatomes  and  the  tempo-
al  block  probably  due  to  the  block  of  the  sympathetic
anglia  in  the  thoracic  paravertebral  space.16 The  more
nterior  approaches  provide  an  analgesia  in  the  abdom-
nal  wall  in  line  with  the  pharmacokinetics  of  the  LA
sed.
The  ultrasound-guided  TAP  has  been  used  and  evaluated
n  RCTs  in  colorectal  surgery,17,18 cesarean,19--27 cholecys-
ectomy,28--32 hysterectomy,33--36 inguinal  herniorrhaphy,37,38
ppendectomy,39 nephrectomy,40,41 bariatric  surgery42,43 and
astrectomy.44 In  addition,  it  has  been  used  and  evaluated
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fEfﬁcacy  of  ultrasound-guided  transverse  abdominal  plan  blo
in  prospective  studies  in  liver  transplantation45 and  in
prostatectomy.46
It  is  important  to  note  that  in  spite  of  TAP  providing  anal-
gesia  in  the  skin,  subcutaneous  and  parietal  peritoneum,  it
should  be  always  executed  as  an  extra  component  in  the
multimodal  analgesia,  because  it  is  not  effective  in  the  con-
trol  of  visceral  pain.47,48
Due  to  the  fact  that  diverse  techniques  and  interven-
tions  in  which  the  ultrasound-guided  TAP  has  been  used,
its  indications  are  not  determined.49 The  objective  of  this
review  is  to  determine  the  efﬁcacy  of  the  ultrasound-guided
TAP  for  different  surgical  interventions  in  those  RCTs  where
ultrasound-guided  TAP  has  been  executed,  and  to  observe
how  it  affects  the  analgesia.  It  also  investigates  the  indi-
cations  according  to  the  approaches,  their  inﬂuence,  the
inﬂuence  of  TAP  duration,  and  the  dose  and  type  of  the  used
LA,  in  addition  to  complications  and  the  assessment,  or  its
lack,  of  the  blockade’s  sensitive  level.
Methods
A  systematic  review  about  the  analgesic  efﬁcacy  of  the
ultrasound-guided  TAP  is  performed  according  to  the  rec-
ommendation  established  by  Preferred  Reporting  Items  for
Systematic  reviews  and  Meta-Analysis  (PRISMA).50
The  authors  searched  in  the  US  National  Library  of
Medicine  database  (MEDLINE)  for  the  terms  «TAP  block»,
«Transversus  Abdominal  Plane  Block», «Transversus  Abdo-
minis  Plane  Block», «Bloqueo  del  Plano  Transverso  del
Abdomen» and  «Bloqueo  TAP», as  well  as  manually.  The
search  was  restricted  to  prospective  RCT  in  humans,  pub-
lished  between  January  2007  and  October  2013,  in  English
or  Spanish.  The  found  RCTs  were  evaluated  in  order  to
identify  those  in  which  ultrasound-guided  TAP  is  compared
to  another  analgesic  modality  in  adult  patient.  The  RCTs
with  Jadad  score  <  251 (Fig.  1)  were  not  included.  The  RCTs
selected  for  the  systematic  review  were  the  ones  in  which  an
intervention  is  performed  with  ultrasound-guided  TAPs  that
compare  the  analgesic  efﬁcacy  in  relation  to  another  tech-
nique  in  adult  humans,  published  between  2007  and  October
2013,  in  English  or  Spanish,  with  Jadad  score  >  1.  There  are
RCTs  in  which  the  analgesic  efﬁcacy  is  evaluated  according
to  the  approach  based  on  references  or  attended  by  a  sur-
geon.  However,  in  this  review,  the  authors  limited  the  search
to  RCT  with  ultrasound-guided  TAP  since  they  consider  that
currently  this  technique  should  be  the  technique  of  election,
because  of  the  diminution  of  block  failure,  the  avoidable
complications  with  the  ultrasound-guided  technique,  and
the  greater  possible  variety  of  approaches.
Two  independent  investigators  (J.  Ripollés  and  S.
Marman˜a)  reviewed  each  article  in  order  to  determine  the
r
c
w
p
Does the study describe itself as randomized? Yes = 1 point; No = 0 points
Is the method utilized for producing the sequence of randomization describe
the method is not appropriate = - 1 point
Does the study describe itself as double-blind? 
Yes = 1 point; No = 0 points
Is the blinding method described? and Is this method appropriate?
Yes = 1 point; No = 0 points; the method is not appropriate = - 1 point
Is there a description of withdrawals and dropouts? 
Yes = 1 point; No = 0 points This questionnaire returns a punctuation in a s
that the evaluated RCT has a better methodological quality. Rigorous 5 poin
Figure  1  Jade  257
ligible  ones.  The  investigators  have  extracted  the  data
ndependently  by  means  of  tables  made  for  this  purpose  and
olved  discrepancies  before  analyzing  the  results.  Demo-
raphic  data,  which  included  author,  year  of  publication,
articipant,  intervention,  outcomes,  design  and  Jadad  score
ere  extracted  from  the  included  RCT  (Table  1).  For  the
nalysis  of  the  analgesic  efﬁcacy,  the  data  extracted  were:
ain  score  at  rest  and  in  early  and  late  movement,  early  and
ate  consumption  of  analgesic  (by  means  of  <12  h  as  early  and
12  h  as  late),  time  until  rescue  analgesia,  and  secondary
ffects  of  opioids:  postoperative  nausea  and  vomit  (PONV),
edation  and  itching  (Table  2).  An  analysis  of  the  technique
sed  for  the  TAP  was  performed,  including:  type  of  surgery,
ype  of  block,  duration,  laterality  of  the  block,  the  nee-
le  used,  drug,  doses  and  volume  utilized,  supplemental
nalgesia  administered,  identiﬁcation  of  sensitive  level  and
omplications  associated  with  the  TAP  (Table  3).  The  use  of
id-axillary  approach  is  assumed  in  those  trials  in  which  it
as  not  been  speciﬁed.
The  probability  of  methodological  bias  of  each  RCT  was
ndependently  evaluated  by  two  authors,  adopting  the  Jadad
core.
esults
hirty-one  RCTs  were  obtained,  which  aligned  with  the  inclu-
ion  criteria  for  the  systematic  review,17--44 A,  D,  C,  including
193  patients.  The  ﬂow  diagram  of  the  selection  of  the  RCT
s  shown  in  Fig.  2.
The  RCTs  were  divided  into  subgroups  according  to  the
ype  of  the  surgery  in  which  TAP  was  used  for  its  analysis:
olorectal,17,18 cesarean,19--28 cholecystectomy,28--33 hyste-
ectomy,34--37 inguinal  herniorrhaphy,38--40 appendectomy,41
ephrectomy,42,43 bariatric,44,45 gastrectomy46 and  retropu-
ic  prostatectomy.47 Of  the  articles  included,  93.5%  had  a
ood  quality  according  to  Jadad  score.
The  characteristics  of  the  RCT  included  in  the  systematic
eview  are  shown  in  Table  1.
ntervention  and  surgery
he  ultrasound-guided  TAP  in  colorectal  surgery  was  eval-
ated  in  2  RCTs,17,18 in  which  the  TAP  was  compared  to
AP  vs.  epidural  anesthesia17 and  TAP  vs.  placebo  TAP18;
n  the  ﬁrst  case,  it  is  speciﬁed  for  high  abdominal  surgery,
hereas  in  the  second  RCT,  an  analysis  of  subgroups  is  per-
ormed  distinguishing  in  left  (supraumbilical  incision)  and
ight  (infraumbilical  incision).  In  the  ﬁrst  RCT,17 a  sub-
ostal  postoperative  approach  is  utilized,  and  no  differences
ere  found  between  visual  analog  scale  (VAS)  score  for
ain  at  rest  or  in  movement  in  the  ﬁrst  72  h with  TAP  or
d? and Is this method appropriate? Yes = 1 point; No = 0 points; 
cale that goes from 0 to 5, so that the higher punctuation means 
ts; low quality < 3 points.
ad  score.
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Table  1  PICOs  (Patient,  Intervention,  Comparison,  Outcome).
Surgery
Author,  year
N  Intervention  Comparison  Outcome  Design  Jadad  Score
C.  colorectal
Niraj  et  al.,  201117 62  Bilateral  TAP  with  catheter
in high  abdominal  surgery
TAP  vs.  epidural  VAS  pain  score  at  rest  and  in
movement  in  the  ﬁrst  72  h
Randomized  double-blind
trial
5
Walter et  al.,
201318
68  Bilateral  TAP  in  c.  colorectal  TAP  vs.  no  TAP  Consumption  of  opioids  in
the  ﬁrst  24  h
Randomized  double-blind
trial
5
Cesarean
Belavy et  al.,
200919
57  Bilateral  TAP  in  cesarean
with  spinal  anesthesia
TAP  vs.  placebo
TAP
Consumption  of  opioids  in
the  ﬁrst  24  h
Randomized  blind  trial  5
Costello et  al.,
200920
96  Bilateral  TAP  in  cesarean
with  spinal  anesthesia  with
ITM
TAP  vs.  placebo
TAP
VAS  pain  score  at  rest  and  in
movement  in  the  ﬁrst  24  h
Randomized  double-blind
trial
5
Baaj et  al.,  201021 40  Bilateral  TAP  in  cesarean
with  spinal  anesthesia
TAP  vs.  placebo
TAP
Consumption  of  opioids  in
the  ﬁrst  24  h
Randomized  double-blind
trial
3
Kanazi et  al.,
201022
57  ITM  in  cesarean  TAP  vs.
ITM  +  placebo  TAP
Time  until  the  opioid  rescue  Randomized  double-blind
trial
4
Loane et  al.,  201223 66  Bilateral  TAP  in  cesarean
under  spinal  anesthesia
TAP  vs.
ITM  +  placebo  TAP
Consumption  of  opioids  in
the  ﬁrst  24  h
Randomized  double-blind
trial
5
Tan et  al.,  201224 40  Bilateral  TAP  in  cesarean
with  general  anesthesia
TAP  vs.  placebo
TAP
Consumption  of  opioids  in
the  ﬁrst  24  h
Randomized  double-blind
trial
5
Bollag et  al.,
201225
90  Bilateral  TAP  with  clonidine
in cesarean  with  spinal
anesthesia
clonidine  TAP  vs.
TAP  vs.  placebo
TAP
Hyperalgesia  index  of  the
wound  following  TAP
Randomized  double-blind
trial
5
Eslamian et  al.,
201226
50  Bilateral  TAP  in  cesarean
with  general  anesthesia
TAP  vs.  no  TAP  VAS  pain  score  at  rest  and  in
movement  in  the  ﬁrst  24  h
Randomized  double-blind
trial
5
Cánovas et  al.,
201327
90  Bilateral  TAP  in  cesarean
with  spinal  anesthesia
TAP  vs.  placebo
TAP  vs.
ITM  +  placebo  TAP
VAS  pain  score  at  rest  and  in
movement  in  the  ﬁrst  24  h
Randomized  double-blind
trial
5
Lee et  al.,  201328 51  Bilateral  TAP  in  cesarean
with  spinal  anesthesia  with
ITM
TAP  vs.  placebo
TAP
VAS  pain  score  in  movement
in the  ﬁrst  48  h
Randomized  double-blind
trial
5
Cholecystectomy
El-Dawlatly et  al.,
200929
42  Bilateral  TAP  in  laparoscopic
cholecystectomy
TAP  vs.  no  TAP  Consumption  of  opioids  in
the  ﬁrst  24  h
Randomized  double-blind
trial
3
Ra et  al.,  201030 54  Bilateral  TAP  in  laparoscopic
cholecystectomy
TAP  vs.  placebo
TAP
Numerical  and  verbal  pain
score  in  the  ﬁrst  24  h
Randomized  blind  trial  3
Efﬁcacy
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Table  1  (Continued)
Surgery
Author,  year
N  Intervention  Comparison  Outcome  Design  Jadad  Score
Petersen  et  al.,
201231
80  Bilateral  TAP  in  laparoscopic
cholecystectomy
TAP  vs.  placebo
TAP
VAS  pain  score  in  movement
in the  ﬁrst  24  h
Randomized  double-blind
trial
5
Ortiz et  al.,  201232 80  Bilateral  TAP  in  laparoscopic
cholecystectomy
TAP  vs.  inﬁltration VAS  pain  score  in  the  ﬁrst
24  h
Randomized  blind  trial 3
Tolchard et  al.,
201233
43  Bilateral  TAP  in  laparoscopic
cholecystectomy
TAP  vs.  inﬁltration Consumption  of  opioids  in
the  ﬁrst  24  h
Reduction  of  VAS
Randomized  double-blind
trial
5
Gynecological
Grifﬁths et  al.,
201034
65  Bilateral  TAP  in  oncologic
gynecological  surgery
TAP  vs.  placebo Consumption  of  opioids  in
the  ﬁrst  24  h
Reduction  of  VAS
Randomized  double-blind
trial
5
Atim et  al.,  201135 55  Bilateral  TAP  in
hysterectomy
TAP  vs.  TAP
placebo  vs.  local
inﬁltration
VAS  pain  score  at  rest  and  in
movement  in  the  ﬁrst  24  h
Randomized  double-blind
trial
2
De Oliveira  et  al.,
201136
75  Bilateral  TAP  in
gynecological  c.
laparoscopic
TAP  vs.  placebo
TAP
QoR-40  satisfaction  score  Randomized  double-blind
trial
5
Kane et  al.,  201237 56  Bilateral  TAP  in
laparoscopic  hysterectomy
TAP  vs.  no  TAP  Satisfaction  score  QoR-40  Randomized  blind  trial  3
H. inguinal
Aveline  et  al.,
201138
275  Unilateral  TAP  in  inguinal
herniorrhaphy
TAP  vs.  b.
ileoinguinal-
ileohipogastric
VAS  pain  score  at  rest  and  in
movement  in  the  ﬁrst  24  h
Randomized  blind  trial  3
López González
et  al.,  201339
41  Unilateral  TAP  in  inguinal
herniorrhaphy
TAP  vs.  inﬁltration  VAS  pain  score  at  rest  and
im movement  in  the  ﬁrst
24  h
Randomized  blind  trial  2
Petersen et  al.,
201340
90  Unilateral  TAP  in  inguinal
herniorrhaphy
TAP  vs.  Placebo
TAP  vs.
IIB  +  inﬁltration  LA
VAS  pain  score  at  rest  and  in
movement  in  the  ﬁrst  24  h
Randomized  double-blind
trial
5
Appendectomy
Niraj et  al.,  200941 52  Unilateral  TAP  in  open
appendectomy
TAP  vs.  no  TAP  Consumption  of  opioids  in
the  ﬁrst  24  h
Randomized  double-blind
trial
5
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Table  1  (Continued)
Surgery
Author,  year
N  Intervention  Comparison  Outcome  Design  Jadad  Score
Nephrectomy
Hosgood  et  al.,
201242
46  TAP  in  donor  nephrectomy  TAP  vs.  placebo
TAP
Consumption  of  opioids  in
the  ﬁrst  48  h  and  VAS  pain
score
Randomized  double-blind
trial
5
Parikh et  al.,
201343
60  TAP  in  donor  nephrectomy  TAP  vs.  placebo
TAP
Consumption  of  opioids  in
the  ﬁrst  24  h
Randomized  double-blind
trial
5
Bariatric
Sinha et  al.,  201344 100  TAP  in  bariatric  surgery
(laparoscopic  Y-Roux
anastomosis)
TAP  vs.  placebo
TAP
Consumption  of  opioids  in
the  ﬁrst  24  h
Randomized  double-blind
trial
5
Albrecht et  al.,
201345
70  TAP  in  bariatric  surgery  with
local  inﬁltration  LA
TAP  vs.  no  TAP  Consumption  of  opioids  in
the  ﬁrst  24  h
Randomized  double-blind
trial
5
Gastrectomy
Wu et  al.,  201346 90  TAP  in  radical  gastrectomy  TAP  vs.  epidural
vs.  no  intervention
Consumption  of  opioids  in
the  ﬁrst  24  h  and  VAS  pain
score
Randomized  double-blind
trial
5
Elkassabany et  al.,
201347
52  Bilateral  TAP  in  retropubic
radical  prostatectomy
TAP  vs.  placebo
TAP
VAS  pain  score  and
consumption  of  opioids  in
the ﬁrst  24  h
Randomized  double-blind
trial
5
LA, local anesthetic; IIB, ilioinguinal block; VAS, visual analog scale; ITM, intrathecal morphine; TAP, transverse abdominis plan.
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Table  2  Analgesic  efﬁcacy.
Author,  year N  Groups  (n) Pain  score  --
at  rest
Pain  score  --
in  movement
Consumption
of  analgesics
Opioid
rescue  time
Adverse  effects
related  to  opioids
Conclusions
Early  Late  Early  Late  Early  Late  NVPO  Itching  Sedation
Niraj  et  al.,
201117
62  1  -- TAP  n  27
2 -- TAP  n  31
NA  −  NA  NA  There  is  no  difference
between  VAS  score  in
rest  and  during
movements  in  the
ﬁrst  72  h  with  TAP  or
epidural
Walter et  al.,
201318
68  1  -- TAP  n  33
2 -- No  TAP  n
35
NA  NA  TAP  reduces  around
33%  the  mean
consumption  of
opioids  in  the  ﬁrst
24 h  (20  mg);  p  <  0.05
Belavy et  al.,
200919
57  1  -- TAP  n  23
2 -- placebo
TAP  n  24
NA  +  −  TAP  reduces  the
mean  consumption  of
opioids  in  the  ﬁrst
24 h  (13.5  mg);
p <  0.05
Costello et  al.,
200920
96  1  --  TAP  n  47
2 --  placebo
TAP  n  49
ND  No  NA  NA  NA  TAP  does  not  reduce
the  VAS  score  in  the
ﬁrst  24  h
Baaj et  al.,
201021
40  1  --  TAP  n  20
2 --  placebo
TAP  n  20
+  +  +  +  NA  NA  +  NA  NA  TAP  reduces  the
mean  consumption  of
opioids  in  the  ﬁrst
24 h  (25.89  mg  vs.
62  mg;  p  <  0.05)
Kanazi et  al.,
201022
57  1  -- ITM  n  28
2 --  TAP  n  29
−  −  NA  −  +  +  TAP  extends  around
50%  (TAP  8  h,  MIT  4  h)
the  time  since  the
ﬁrst  opioid  rescue
(p  <  0.05)
Loane et  al.,
201223
66  1  -- TAP  n  33
2 --
ITM  +  placebo
TAP  n  33
−  −  −  −  NA  +  +  TAP  increases  the
mean  consumption  of
opioids  in  the  ﬁrst
24 h  (7.5  mg  vs.
2.7  mg;  p  =  0.03)
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Table  2  (Continued)
Author,  year  N  Groups  (n)  Pain  score  --
at  rest
Pain  score  --
in  movement
Consumption
of  analgesics
Opioid
rescue  time
Adverse  effects
related  to  opioids
Conclusions
Early  Late  Early  Late  Early  Late  NVPO  Itching  Sedation
Tan  et  al.,
201224
40  1  --  TAP  n  20
2 --  placebo
TAP  n  20
NA  NA  TAP  reduces  the
mean  consumption  of
opioids  in  the  ﬁrst
24  h  (12.3  mg  vs.
31.4  mg;  p  <  0.01)
Bollag et  al.,
201225
90  1  --  TAP
placebo  n  30
2  --  TAP  n  25
3 --  TAP
clonidine  n
26
−  −  +  +  NA  NA  NA  NA  To  add  clonidine  to
TAP  with  bupivacaine
does  not  improve  the
injuries  hyperalgesia
rate,  and  it  does  not
improve  the  VAS
score  at  rest  and  in
movement
Eslamian et  al.,
201226
50  1  --  TAP  n  23
2 --  No  TAP  n
25
+  +  +  +  +  +  NA  NA  NA  TAP  reduces  the  VAS
score  at  rest  and  in
movement,  as  well  as
the  consumption  of
opioids  in  the  ﬁrst
24  h  (50  mg  tramadol
vs.  150  mg  tramadol;
p  =  0.0001)
Cánovas et  al.,
201327
90  1  --
ITM  +  placebo
TAP  n  30
2  --  placebo
TAP
3  --  TAP
+  +  +  +  +  +  +  +  +  TAP  reduces  the  VAS
score  at  rest,  12/24  h
(p <  0.05),  and  in
movement  (p  ≤  0.02)
Lee et  al.,
201328
51  1  --  TAP  n  26
2 --  placebo
TAP  n  25
+  +  +  +  TAP  reduces  the  pain
score  at  rest  and  in
movement  in  the  ﬁrst
2 postoperative  hours
(0.5  and  1.9  vs.  2.8
and  4.9;  p  <  0.001)
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Table  2  (Continued)
Author,  year  N  Groups  (n)  Pain  score  --
at  rest
Pain  score  --
in  movement
Consumption
of  analgesics
Opioid
rescue  time
Adverse  effects
related  to  opioids
Conclusions
Early  Late  Early  Late  Early  Late  NVPO  Itching  Sedation
El-Dawlatly
et  al.,  200929
42  1  -- TAP  n  21
2 -- No  TAP  n
21
NA  NA  NA  NA  +  +  NA  NA  NA  NA  TAP  reduces  the
intraoperative
consumption  of
sufentanyl  (p  <  0.01),
and  also  reduces  the
consumption  of
morphine  in  the  ﬁrst
24  h  (12.3  mg;
p <  0.05)
Ra et  al.,
201030
54  1  -- TAP  0.5%
n  18
2 -- TAP
0.25%  n  18
3 --  No  TAP
+  +  +  +  +  +  NA  NA  NA  +  TAP  0.25%  and  TAP
0.5%  reduce
verbal-numerical  pain
score  in  the  ﬁrst  24  h
(p <  0.001).  There  are
no  differences
between  TAP  0.25%
and  TAP  0.5%.  TAP
reduces  the
consumption  of
intraoperative
remifentanyl  and  also
reduces  the
consumption  of
analgesics  in
postoperative
(p  <  0.001).  There  are
no  differences
between  TAP  0.25%
and  TAP  0.5%
Petersen et  al.,
201231
80  1  -- TAP  n  37
2 -- placebo
TAP  n  37
+  +  +  NA  NA  TAP  reduces  the  VAS
pain  score  in
movement,
calculated  as  the  area
under  the  curve  in
the  ﬁrst  24  h  (26  mm
vs. 34  mm;  p  =  0.04)
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Table  2  (Continued)
Author,  year  N  Groups  (n)  Pain  score  --
at  rest
Pain  score  --
in  movement
Consumption
of  analgesics
Opioid
rescue  time
Adverse  effects
related  to  opioids
Conclusions
Early  Late  Early  Late  Early  Late  NVPO  Itching  Sedation
Ortiz  et  al.,
201232
80  1  --  TAP  n  39
2 --  local
inﬁltration  n
35
NA  NA  NA  NA  NA  TAP  does  not  reduce
the  VAS  score  in  the
ﬁrst  24  h
Tolchard et  al.,
201233
43  1  --  TAP  n  21
2 --  local
inﬁltration  n
22
+  NA  +  NA  −  NA  NA  NA  NA  TAP  reduces  VAS  in
the  ﬁrst  8  h  (p  <  0.01)
TAP  reduces  the
consumption  of
opioids  in  the  ﬁrst  8  h
(9.2 mg  vs.  16.8  mg;
p <  0.01)
Grifﬁths et  al.,
201034
65  1  --  TAP  n  32
2 --  placebo
TAP  n  33
NA  TAP  does  not  reduce
the  consumption  of
opioids  in  the  ﬁrst
24  h.  TAP  does  not
reduce  VAS  in  the  ﬁrst
2 postoperative
hours.
Atim et  al.,
201135
55  1  --  TAP  n  18
2 --  placebo
TAP  n  18
3  --  local
inﬁltration  n
19
+  +  +  +  +  NA  NA  TAP  and  inﬁltration
reduce  the  pain  score
at  rest  and  in
movement  at  the
hours  1,  2,  4,  6,  24
(p  <  0.0001).  TAP
reduces  the  pain
score  at  rest  and  in
movement  at  the
hours  6  and  24
regarding  the
inﬁltration  (p  <  0.001)
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Table  2  (Continued)
Author,  year  N  Groups  (n)  Pain  score  --
at  rest
Pain  score  --
in  movement
Consumption
of  analgesics
Opioid
rescue  time
Adverse  effects
related  to  opioids
Conclusions
Early  Late  Early  Late  Early  Late  NVPO  Itching  Sedation
De  Oliveira
et  al.,  201136
75  1  -- TAP
0.25%  n  23
2 -- TAP  0.5%
n  24
3 -- placebo
TAP  n  23
+  +  +  +  +  +  NA  NA  NA  NA  TAP  improves  the
QoR-40  satisfaction
score;  average  of  16
ropivacaine  0.5%  and
17 ropivacaine  0.25%
vs.  saline  (p  <  0.05).
There  are  no
differences  between
ropivacaine  0.5%  vs.
ropivacaine  0.25%
Kane et  al.,
201237
56  1  -- TAP  n  28
2 -- No  TAP  n
28
NA  NA  NA  TAP  does  not  reduce
the  QoR-40  score  or
VAS  scale.  It  does  not
reduce  or  increase
the  consumption  of
opioids
Aveline et  al.,
201138
275  1  --  TAP  n  132
2 --  IHB  n  139
+ +  +  +  NA  NA  NA  NA  TAP  reduces  the  pain
score  at  early
(average  11  vs.  15;
p  =  0.04)  and  late
(average  29  vs.  33;
p  =  0.013)  rest.  TAP
reduces  the  mean
consumption  of
opioids  in  the  ﬁrst
24 h;  p  =  0.03
López González
et  al.,  201339
41  1  --  TAP  n  20
2 --  local
inﬁltration  n
21
+  + a Signiﬁcant
differences  were  not
detected  in  VAS  pain
score  between  rest
and  movement.  TAP
reduces  the  mean
consumption  of
opioids  in  the  ﬁrst
24 h  (0.3  mg  vs.
1.05  mg;  p  <  0.05)
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Table  2  (Continued)
Author,  year  N  Groups  (n)  Pain  score  --
at  rest
Pain  score  --
in  movement
Consumption
of  analgesics
Opioid
rescue  time
Adverse  effects
related  to  opioids
Conclusions
Early  Late  Early  Late  Early  Late  NVPO  Itching  Sedation
Petersen  et  al.,
201340
90  1  --  TAP  n  30
2 --  Inﬁltra-
tion/IIB  30
3  --  placebo
TAP  n  30
−  −  −  TAP  does  not  reduce
the  pain  score  at  rest
or in  movement  in
the  ﬁrst  24  h
Niraj et  al.,
200941
52  1  --  TAP  n  25
2 --  No  TAP  n
26
+  +  +  +  NA  +  NA  NA  TAP  reduces  the
mean  consumption  of
opioids  in  the  ﬁrst
24  h  (28  mg  vs.  50  mg;
p <  0.002)
Hosgood et  al.,
201242
51  1  --  TAP  n  25
2 --  placebo
TAP  n  25
+  +  +  +  +  +  +  NA  TAP  reduces  the
mean  consumption  of
opioids  in  the  ﬁrst  24
postoperative  hours
(12.4  mg  vs.  21.  6  mg;
p  =  0.015).  There  is  no
signiﬁcant  difference
in the  cumulative
consumption  of
opioids  in  the  ﬁrst
48  h
Parikh et  al.,
201343
60  1  --  TAP  n  30
2 --  placebo
TAP  n  30
+  +  +  +  +  NA  TAP  reduces  the
mean  consumption  of
opioids  in  the  ﬁrst
24  h
(103.8  ±  32.18  mg  vs.
235.8  ±  47.5  mg)
Sinha et  al.,
201344
100  1  --  TAP  n  50
2 --  placebo
TAP  n  50
+  +  +  +  +  +  NA  +  TAP  reduces  the
mean  consumption  of
opioids  in  the  ﬁrst
24  h  (8  mg  vs.  48  mg;
p =  0.000)
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Table  2  (Continued)
Author,  year N  Groups  (n) Pain  score  --
at  rest
Pain  score  --
in  movement
Consumption
of  analgesics
Opioid
rescue  time
Adverse  effects
related  to  opioids
Conclusions
Early  Late  Early  Late  Early  Late  NVPO  Itching  Sedation
Albrecht  et  al.,
201345
70  1  -- TAP  n  25
2 -- No  TAP  n
28
There  are  no
differences  between
the  consumption  of
opioids  TAP  and
control  in  the  ﬁrst  4
postoperative  hours
(32.2  mg  vs.  35.6  mg;
p  =  0.41)
Wu et  al.,
201346
90  1  -- TAP  n  29
2 -- Epidural
n  27
3 -- Control  n
26
−/+ −/+  NA  TAP  is  better  than
general  anesthesia
regarding  the
consumption  of
opioids  in  the  ﬁrst
24 h.  Epidural  is
better  than  TAP
regarding  the
consumption  of
opioids  in  the  ﬁrst
24 h
Elkassabany
et al.,  201347
52  1  -- TAP  n  16
2 -- placebo
TAP  n  16
+  −  +  −  +  −  +  −  NA  NA  TAP  reduces  the
mean  consumption  of
opioids  in  the  ﬁrst
24 h  (22.1  mg  vs.
45.5  mg,)
IHB, iliohypogastric block; IIB, ilioinguinal block; VAS, visual analog scale; ITM, intrathecal morphine; NA, not available; TAP, transverse abdominis plan; +, favorable to TAP; −, favorable
to comparator.
a No differences.
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Table  3  Technique  of  block.
Author,  year  Type  of
block
Technique  Time  Needle  Anesthetic
used  by
injection
Complications  Sensitive  level
of  the  block
Block
duration
Additional
analgesia
Conclusions
Niraj  et  al.,
201117
Bilateral  Subcostal  Postoperative  16  G  80  mm  1  mg  kg−1
bupivacaine
0.375%
No  No  NA  Paracetamol
1  g
Tramadol
50--100  mg
There  are  no  differences
between  VAS  pain  score
at  rest  or  in  movement
in  the  ﬁrst  72  h,  with  TAP
or epidural
Walter et  al.,
201318
Bilateral  ND  Preoperative  ND  40  ml.
Levobupiva-
caine
2  mg  kg−1
(maximum
150  mg)
No  No  NA  Paracetamol
1  g
TAP  reduces  in  33%  the
mean  consumption  of
opioids  in  the  ﬁrst  24  h
(20  mg),  p  <  0.05
Belavy et  al.,
200919
Bilateral  Mid-axillary  Postoperative  20  G  150  mm  20  ml
ropivacaine
0.5%
No  No  NA  Paracetamol
1  g
Diclofenac
100  mg
TAP  reduces  the  mean
consumption  of  opioids
in the  ﬁrst  24  h
(13.5  mg),  p  <  0.05
Costello et  al.,
200920
Bilateral  Mid-axillary  Postoperative  20  G  64  mm  20  ml
ropivacaine
0.375%
No  No  No  Ketorolac
30  mg
Paracetamol
1.3  g  rectal
TAP  does  not  reduce  VAS
score  in  the  ﬁrst  24  h
Baaj et  al.,
201021
Bilateral  Mid-axillary  Preoperative  20  G  100  mm  20  ml
bupivacaine
0.25%
No  No  NA  No  TAP  reduces  the  mean
consumption  of  opioids
in the  ﬁrst  24  h,
(25.89  mg  vs.  62  mg;
p  <  0.05)
Kanazi et  al.,
201022
Bilateral  Mid-axillary  Postoperative  21  G  100  mm  20  ml
levobupiva-
caine
0.375  +
adrenaline
No  No  NA  Paracetamol
1  g
Diclofenac
100  mg
TAP  extends  50%  (TAP
8 h,  MIT  4  h)  of  the  time
until  the  ﬁrst  opioid
rescue,  p  <  0.05
Loane et  al.,
201223
Bilateral  Mid-axillary  Postoperative  22  G  80  mm  Ropivacaine
1.5  mg  kg−1
maximum
20  ml
No  No  NA  Naproxen
500  mg
Paracetamol
1  g
TAP  increases  the  mean
consumption  of  opioids
in the  ﬁrst  24  h,  (7.5  mg
vs.  2.7  mg;  p  =  0.03)
Tan et  al.,
201224
Bilateral  Mid-axillary  Postoperative  22  G  70  mm  20  ml
levobupiva-
caine
0.25%
No  No  NA  Morphine
chloride
0.15  mg  kg−1
TAP  reduces  the  mean
consumption  of  opioids
in the  ﬁrst  24  h  (12.3  mg
vs.  31.4  mg;  p  <  0.01)
Efﬁcacy
 of
 ultrasound-guided
 transverse
 abdom
inal
 plan
 blockade
 
269
Table  3  (Continued)
Author,  year Type  of
block
Technique Time Needle  Anesthetic
used  by
injection
Complications  Sensitive  level
of  the  block
Block
duration
Additional
analgesia
Conclusions
Bollag  et  al.,
201225
Bilateral  Mid-axillary  Postoperative 20  G 20  ml
ropivacaine
0.375%
No  No  NA  Paracetamol
1  g
Diclofenac
75  mg
Tramadol
To  add  clonidine  to  TAP
with  bupivacaine  does
not improve  the  wound
hyperalgesia  rate,  and  it
does  not  improve  the
VAS score  at  rest  and  in
movement
Eslamian et  al.,
201226
Bilateral  Mid-axillary  Postoperative 22  G  50  mm 15  ml
bupivacaine
0.25%
No  No  NA  Diclofenac
100  mg
TAP  reduces  the  VAS
score  at  rest  and  in
movement,  as  well  as
the  consumption  of
opioids  in  the  ﬁrst  24  h
(50  mg  tramadol  vs.
150  mg  tramadol;
p  =  0.0001)
Cánovas et  al.,
201327
Bilateral  Mid-axillary  Postoperative  20  G  20  ml
levobupiva-
caine
0.5%
No  No  NA  Morphine
chloride
TAP  reduces  VAS  at  rest,
12/24  h  (p  <  0.05),  and  in
movement  (p  ≤  0.02)
Lee et  al.,
201328
Bilateral  Mid-axillary  Postoperative  21  G  90  mm  20  ml
ropivacaine
0.5%
No  No  NA  Paracetamol
1  g
Ketorolac
50  mg
Morphine
chloride
TAP  reduces  the  pain
score  at  rest  and  in
movement  in  the  ﬁrst  2
postoperative  hours  (0.5
and  1.9  vs.  2.8  and  4.9;
p <  0.001)
El-Dawlatly
et al.,  200929
Bilateral  Mid-axillary  Preoperative  21  G  90  mm  15  ml
bupivacaine
0.5
No  No  NA  NA  TAP  reduces  the
intraoperative
consumption  of
sufentanil  (p  <  0.01)  as
well  as  the  consumption
of  morphine  in  the  ﬁrst
24 h  (12.3  mg;  p  <  0.05)
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Table  3  (Continued)
Author,  year  Type  of
block
Technique  Time  Needle  Anesthetic
used  by
injection
Complications  Sensitive  level
of  the  block
Block
duration
Additional
analgesia
Conclusions
Ra  et  al.,
201030
Bilateral  Mid-axillary  Preoperative  22  G  50  mm  15  ml
bupivacaine
0.25%  o
15  ml
bupivacaine
0.5%
No  No  NA  Ketorolac
30  mg
Fentanyl
TAP  0.25%  and  TAP  0.5%
reduce  the
verbal-numerical  pain
score  in  the  ﬁrst  24  h
(p <  0.001).  There  are  no
differences  between  TAP
0.25%  and  TAP  0.5%.  TAP
reduces  the  consumption
of intraoperative
remifentanyl  as  well  as
the  use  of  postoperative
analgesics  (p  <  0.001).
There  are  no  differences
between  TAP  0.25%  and
TAP  0.5%
L. Petersen
et  al.,  201231
Bilateral  Mid-axillary  Preoperative  22  G  80  mm  20  ml
ropivacaine
0.5%
No  No  24  h  Paracetamol
1  g
Ibuprofen
600  mg
Morphine
chloride
TAP  reduces  the  VAS  pain
score  movement,
calculated  as  the  area
under  the  curve  in  the
ﬁrst  24  h  (26  mm  vs.
34  mm;  p  =  0.04)
Ortiz et  al.,
201232
Bilateral  Mid-axillary  Preoperative  21  G  100  mm  15  ml
bupivacaine
0>,5%
No  No  NA  Ketorolac
30  mg
TAP  does  not  reduce  the
VAS  score  in  the  ﬁrst  24  h
Tolchard et  al.,
201233
Bilateral  Subcostal  Preoperative  22  G  100  mm  Bupivacaine
1  mg  kg−1
(average
22  ml)
No  No  NA  Codeine  TAP  reduces  VAS  in  the
ﬁrst  8  h  (p  <  0.01)
TAP  reduces  the
consumption  of  opioids
in the  ﬁrst  8  h,  (9.2  mg
vs.  16.8  mg;  p  <  0.01)
Grifﬁths et  al.,
201034
Bilateral  Mid-axillary  Postoperative  90  mm  20  ml
ropivacaine
0.5%
No  No  NA  Paracetamol
1  g,
parecoxib
40  mg
TAP  does  not  reduce  the
consumption  of  opioids
in the  ﬁrst  24  h.  TAP
does  not  reduce  VAS  in
the  ﬁrst  2  postoperative
hours
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Table  3  (Continued)
Author,  year Type  of
block
Technique Time Needle  Anesthetic
used  by
injection
Complications  Sensitive  level
of  the  block
Block
duration
Additional
analgesia
Conclusions
Atim  et  al.,
201135
Bilateral  Medial
armpit
Preoperative 20  G  100  mm 20  ml
bupivacaine
0.25%
No  No  NA  Diclofenac
75  mg
Tramadol
0.5  mg  kg−1
TAP  and  inﬁltration
reduce  the  pain  score  at
rest  and  in  movement  at
the hours  1,  2,  4,  6,  24
(p <  0.0001).  TAP  reduces
the  pain  score  at  rest
and  in  movement  at  the
hours  6  and  24  regarding
the  inﬁltration
(p  <  0.001)
De Oliveira
et  al.,  201136
Bilateral  Mid-axillary  Preoperative 21  G  90  mm 15  ml
ropivacaine
0.25%  o  0.5%
No  No  NA  Ketorolac
30  mg
TAP  improves  the  QoR-40
satisfaction  score;
average  16  ropivacaine
0.5%  and  17  ropivacaine
0.25%  vs.  saline;
p  <  0.05.  There  are  no
differences  between
ropivacaine  0.5%  vs.
ropivacaine  0.25%
Kane et  al.,
201237
Bilateral  NA  Postoperative  NA  20  ml
ropivacaine
0.5%  +
adrenaline
No  No  NA  NA  TAP  does  not  reduce
QoR-40  score  or  VAS
score.  It  does  not  reduce
or increase  the
consumption  of  opioids
Aveline et  al.,
201138
Unilateral  Mid-axillary  Preoperative  22  G  1.5  mg  kg−1
levobupiva-
caine
0.5%
No  No  NA  Paracetamol
1  g
Ketoprofen
100  mg
TAP  reduces  the  pain
score  at  early  (average
11  vs.  15;  p  =  0.04)  and
late  (average  29  vs.  33;
p  =  0.013)  rest.  TAP
reduces  the  mean
consumption  of  opioids
in  the  ﬁrst  24  h  (p  =  0.03)
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Author,  year  Type  of
block
Technique  Time  Needle  Anesthetic
used  by
injection
Complications  Sensitive  level
of  the  block
Block
duration
Additional
analgesia
Conclusions
López  González
et  al.,  201339
Unilateral  Mid-axillary  Preoperative  NA  30  ml
bupivacaine
0.25%
No  No  NA  Paracetamol  1  g
Dexketoprofen
50  mg
Morphine  chloride
Signiﬁcant  differences
were  not  detected  in  VAS
pain  score  between  at
rest  and  in  movement.
TAP  reduces  the  mean
consumption  of  opioids
in the  ﬁrst  24  h  (0.3  mg
vs.  1.05  mg;  p  <  0.05)
Petersen et  al.,
201340
Unilateral  Mid-axillary  Preoperative  22  G  80  mm  25  ml
ropivacaine
0.75%
No  No  NA  Ketebidona  TAP  does  not  reduce  the
pain  scale  at  rest  or  in
movement  in  the  ﬁrst
24 h
Niraj et  al.,
200941
Unilateral  Mid-axillary  Postoperative  23  G  60  mm  20  ml
ropivacaine
0.5%
No  No  NA  Paracetamol  1  g
Diclofenac  50  mg
TAP  reduces  the  mean
consumption  of  opioids
in the  ﬁrst  24  h  (28  mg
vs.  50  mg;  p  <  0.002)
Hosgood et  al.,
201242
Unilateral  Mid-axillary  Preoperative  22  G  20  ml
ropivacaine
0.375%
No  No  NA  Paracetamol  1  g
Morphine  chloride
TAP  reduces  the  mean
consumption  of  opioids
in the  ﬁrst  6
postoperative  hours
(12.4  mg  vs.  21.6  mg;
p  =  0.015).  There  is  no
signiﬁcant  difference  in
the  cumulative
consumption  of  opioids
in the  ﬁrst  48  h
Parikh et  al.,
201343
Unilateral  Mid-axillary  Postoperative  18  G  tohuy  25  ml
bupivacaine
0.375%
No  No  NA  Diclofenac
1.5  mg  kg−1
Tramadol
TAP  reduces  the  mean
consumption  of  opioids
in the  ﬁrst  24  h
(103.8  ±  32.18  mg  vs.
235.8  ±  47.5  mg)
Sinha et  al.,
201344
Bilateral  Modiﬁed
mid-axillary
Postoperative  NA  20  ml
ropivacaine
0.375%
No  No  No  NA  TAP  reduces  the  mean
consumption  of  opioids
in the  ﬁrst  24  h  (8  mg  vs.
48  mg;  p  =  0.000)
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Table  3  (Continued)
Author,  year Type  of
block
Technique Time Needle  Anesthetic  used  by
injection
Complications  Sensitive  level
of  the  block
Block
duration
Additional
analgesia
Conclusions
Albrecht  et  al.,
201345
Bilateral  Oblique
subcostal
Preoperative 22  G  80  mm 30  ml  bupivacaine
0.25%  +  adrenaline
No  No  No  Paracetamol
1  g
Oxycodone
5--10  mg
There  are  no  differences
in the  consumption  of
opioids  between  TAP  and
control  in  the  ﬁrst  24
postoperative  hours
(32.2  mg  vs.  35.6  mg;
p  =  0.41)
Wu et  al.,
201346
Bilateral  Oblique
subcostal
Preoperative ND  20  ml  ropivacaine
0.375%
No  No  No  Morphine
chloride
TAP  is  better  than
general  anesthesia
regarding  the
consumption  of  opioids
in  the  ﬁrst  24  h.  Epidural
is better  than  TAP
regarding  the
consumption  of  opioids
in  the  ﬁrst  24  h
Elkassabany
et al.,  201347
Bilateral  Mid-axillary  Postoperative  22  G  20  ml  bupivacaine
0.5%
No  No  No  Morphine
chloride
TAP  reduces  the  mean
consumption  of  opioids
in  the  ﬁrst  24  h  (22.1  mg
vs.  45.5  mg)
VAS, visual analog scale; ITM, intrathecal morphine; NA, not available; TAP, transverse abdominis plan.
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Transversus abdominal plane blockTAP block
Citations in Pubmed 478
208 articles analyzed
270 articles excluded
(no human, no English, no Spanish)
129 articles excluded 
(no RCT, randomized, blind)
56 RCT articles
for analysis
25 RCT included
for systematic review
Manual search 6 
RCT included
31 RCT included for
systematic review
26 articles excluded
They do not fulfill the inclusion
criteria (adult, ecoguided,
analgesic efficacy, Jadad > 2)
Transversus abdominal plane block
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pidural.  In  the  second  RCT,18 a  preoperative  mid-axillary
pproach  was  performed  and  a  reduction  of  33%  in  the
ean  consumption  of  opioids  was  observed  in  the  ﬁrst  24  h
20  mg)  (p  <  0.05),  mainly  due  to  the  infraumbilical  surgery,
lthough  the  consumption  of  opioids  in  the  ﬁrst  24  h  in  the
upraumbilical-surgery  subgroup  also  decreased.  Decrease
f  PONV,  sedation  or  itching  was  observed  in  none  of  the
ases.
The  ultrasound-guided  TAP  in  cesarean  was  evaluated
n  10  RCTs.  Among  those,  cesarean  with  spinal  anesthe-
ia  was  evaluated  in  8  RCTs19--23,25,27;  of  which  420,22,23,27
ompared  TAP  vs.  spinal  morphine  (ITM),  2  compared  vs.
lacebo  TAP,19,21 and  in  one  the  addition  of  clonidine  in
AP  vs.  TAP  vs.  placebo  TAP,26 and  recently  the  analgesic
ffect  TAP  in  cesarean  with  spinal  anesthesia  with  ITM  was
valuated.28In  2  RCTs,  TAP  with  cesarean  was  compared  to  gen-
ral  anesthesia.24,26 In  all  cases,  the  block  was  carried  out
fter  the  cesarean,  through  bilateral  mid-axillary  approach;
n  none  there  were  complications  associated  with  TAP  nor
i
o
r
tction  of  the  articles  included.
he  sensitive  level  neither  the  duration  of  the  block  were
ltered.19--28
Among  the  RCTs  comparing  TAP  vs.  ITM,  in  Costello  et  al.19
here  were  no  signiﬁcant  differences  in  VAS  in  pain  at  rest  or
n  movement,  or  any  signiﬁcant  reduction  in  time  until  the
pioid  rescue.  Kanazi  et  al.22 demonstrated  that  TAP  pro-
onged  50%  the  time  until  the  opioid  rescue,  and  increased
he  early  VAS  at  rest  and  in  movement,  and  reduced  PONV
nd  itching  in  the  TAP  group.  Similarly,  the  RCTs  carried  out
y  Loane  et  al.23 demonstrated  an  increase  in  the  consump-
ion  of  opioids  in  the  ﬁrst  24  hours  (h)  (7.5  mg  vs.  2.7  mg;
 = 0.03),  as  well  as  an  increase  in  the  VAS  both  at  rest  and
n  early  and  late  movement,  whereas  reduced  the  PONV  and
tching.  Recently,  Cánovas  et  al.27 carried  out  a  RCT  in  the  3
roups  of  patients  undergoing  cesarean  where  spinal  anes-
hesia  was  administered:  in  the  group  A,  0.1  mg  of  morphine,
n  the  group  B,  10  mcg  of  fentanyl,  and  in  the  group  C,  10  mcg
f  fentanyl  and  bilateral  TAP  block.  The  VAS  at  early/late
est  was:  group  A,  at  12  h  2.1  ±  1.2,  and  at  24  h  4.7  ±  1.6;  in
he  group  B,  at  12  h  4.3  ±  2.9,  and  at  24  h  4.8  ±  2.0;  and  in
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TEfﬁcacy  of  ultrasound-guided  transverse  abdominal  plan  blo
the  group  C,  at  12  h  1.9  ±  1.1,  and  at  24  h  2.3  ±  1.2  (p  <  0.05).
When  in  movement,  the  analgesia  was  better  in  the  group  C
(p  ≤  0.02).  The  time  until  the  analgesic  rescue  was  inferior
in  the  group  B:  in  the  group  A,  9.3  ±  4.9  (p  =  0.02  in  com-
parison  to  the  group  C);  in  the  group  B,  2  ±  1.8  (p  <  0.001  in
comparison  to  the  group  C);  and  in  the  group  C,  13.2  ±  2.1  h.
The  consumption  of  opioids  in  the  ﬁrst  24  h  was:  in  the  group
B  38  ±  5,  in  the  group  A,  10  ±  2  (p  <  0.05),  and  in  the  group
C,  5  ±  2  (p  <  0.001).  The  incidence  of  nausea  was  superior  in
the  group  B  (36.6%),  and  the  itching  was  greater  in  group  A
(36.6%).
Bollag  et  al.25 studied  the  effect  of  the  addition  of  cloni-
dine  and  ropivacaine  in  the  execution  of  the  TAP  in  patients
undergoing  cesarean  under  spinal  anesthesia  with  ITM  to
measure  wound  hyperalgesia.  There  were  no  differences
between  ITM,  ITM  with  TAP  and  ITM  with  TAP  and  clonidine.
No  differences  in  the  consumption  of  opioids  or  in  VAS  were
found.
In  the  RCTs  that  compared  TAP  vs.  placebo  TAP  in
cesarean  with  spinal  anesthesia  without  ITM,  Belavy  et  al.19
found  a  decrease  in  the  consumption  of  opioids  in  the  ﬁrst
24  h  (18  mg  vs.  13.5  mg;  p  <  0.05)  and  in  the  time  for  the
ﬁrst  opioid  rescue  (2  h  vs.  3  h;  p  =  0.019).  However,  no  sig-
niﬁcant  differences  in  VAS  at  rest  or  movement  were  found,
as  well  as  for  the  incidence  of  secondary  effects  of  opioids.
Baaj  et  al.21 demonstrated  a  signiﬁcant  reduction  in  the  con-
sumption  of  opioids  in  the  ﬁrst  24  h  (25.89  mg  vs.  62  mg;
p  >  0.05),  as  well  as  a  lessening  of  25%  in  the  VAS  at  rest
and  in  movement  for  the  ﬁrst  24  h,  and  a  decrease  in  PONV.
These  results,  however,  were  not  signiﬁcant.
Lee  et  al.28 demonstrated  that  the  execution  of  bilateral
TAP  in  patients  scheduled  to  cesarean  with  spinal  anesthesia
with  ITM  lessens  signiﬁcantly  the  pain  score  at  rest  or  in
movement  within  the  ﬁrst  2  h  after  the  surgery  (0.5  and  1.9
vs.  2.8  and  4.9;  p  <  0.001).  It  also  decreases  the  consumption
of  analgesics  (0  vs.  25%;  p  =  0.01).  However,  no  signiﬁcant
differences  were  found  in  reducing  the  pain  score  in  the
ﬁrst  24  h  or  in  PONV.
In  the  RCT  that  compare  TAP  vs.  placebo  TAP  in  cesarean
under  general  anesthesia,  Tan  et  al.24 concluded  that  the
TAP  reduces  the  mean  consumption  of  opioids  in  the  ﬁrst  24  h
(12.3  mg  vs.  31.4  mg;  p  <  0.01).  In  addition,  no  signiﬁcant
differences  were  found  in  the  VAS  at  rest  or  in  movement  or
in  the  apparition  of  secondary  effects  of  opioids.  Eslamian
et  al.26 demonstrated  a  decrease  in  the  VAS  at  rest  and  in
movement,  a  reduction  in  the  consumption  of  opioids  in  the
ﬁrst  24  h  (50  mg  vs.  250  mg;  p  =  0.001)  and  an  increase  for  the
opioid  rescue  (210  min  vs.  30  min;  p  =  0.0001);  the  incidence
of  secondary  effects  of  opioids  was  not  evaluated.
The  ultrasound-guided  bilateral  TAP  in  laparoscopic
cholecystectomy  was  studied  in  5  RCTs,29--33 among  whose
placebo  was  compared  with  in  3,29,30 and  no  intervention
in  one28;  and  in  2  of  the  RCTs  to  the  LA  inﬁltration  in
laparoscopic  wounds.32,33 In  all  the  cases,  it  was  executed
bilaterally  and  after  the  operation.  In  four  cases,29,32 a
mid-axillary  approach  was  used,  and  in  one,  subcostal.33
In  the  RCT  where  TAP  is  compared  to  placebo  TAP  or  no
intervention,29--31 El-Dawlatly  et  al.29 compared  the  effect  of
the  TAP  in  laparoscopic  cholecystectomy  vs.  no  intervention
and  demonstrated  a  lower  consumption  of  intraoperative
opioids  (8.6  mcg  vs.  23  mcg;  p  <  0.01),  and  of  morphine  in
the  ﬁrst  24  h  (10.5  mg  vs.  22.8  mg;  p  <  0.05).  Neither  VAS  nor
T
t
t
ne  275
econdary  effects  of  opioids  were  evaluated.  Ra  et  al.30 com-
ared  TAP  with  bupivacaine  0.25%  vs.  TAP  with  bupivacaine
.5%  vs.  placebo  TAP,  demonstrating  that  TAP,  at  both  con-
entrations  in  comparison  with  placebo  reduced  the  numeric
erbal  pain  score  in  the  ﬁrst  24  h  (p  <  0.001),  regardless  the
upivacaine  doses  of  0.25%  and  0.5%.  The  consumption  of
ntraoperative  opioids  and  analgesics  in  the  postoperative
eriod  was  lower  in  the  groups  with  TAP  with  bupivacaine
p  <  0.001),  with  no  inﬂuence  from  different  LA  concentra-
ions  used.  The  control  group  presented  higher  sedation
core  in  the  postoperative  period  in  comparison  with  the
roup  of  TAP  plus  bupivacaine  0.5%.  Petersen  et  al.,31 when
omparing  TAP  vs.  placebo  TAP  found  a  reduction  for  VAS  in
ovement  (calculated  as  an  area  under  the  curve)  in  the
rst  24  h  (26  mm  vs.  34  mm;  p  =  0.04);  as  well  as  a  lower
onsumption  of  opioids  in  the  ﬁrst  2  postoperative  hours
7.5  mg  vs.  5  mg;  p  <  0.001).  There  were  no  differences  in
ONV  or  in  sedation  between  the  two  groups.  In  the  RCT
hat  compare  TAP  vs.  LA  inﬁltration  in  laparoscopic  wounds
n  the  laparoscopic  cholecystectomy,31,32 Ortiz  et  al.32 per-
ormed  a  mid-axillary  approach  and  did  not  ﬁnd  differences
n  the  VAS,  in  the  consumption  of  analgesics  in  the  ﬁrst
4  h,  and  in  PONV.  However,  recently  Tolchard  et  al.,33 from
 subcostal  approach,  demonstrated  that  the  TAP  lowered
he  early  VAS  in  movement  (8  h;  p  <  0.01)  as  well  as  the
onsumption  of  opioids  in  the  ﬁrst  8  h  (9.2  mg  vs.  16.8  mg;
 <  0.01).  The  secondary  effects  of  opioids  were  not  evalu-
ted.
The  TAP  in  gynecologic  surgery  was  evaluated  in
our  RCTs34--37 in  oncogynecological  procedures  via  mid-
aparotomy,34 via  laparoscopy  in  major  outpatient  surgery
egime36 and  in  total  abdominal  hysterectomy  with
fannenstiel35 incision,  and  in  laparoscopic  hysterectomy.37
n  3  of  these,  TAP  vs.  placebo  TAP  or  no  intervention
s  compared,34,36,37 and  in  one,  TAP  vs.  placebo  TAP  vs.
nﬁltration  is  compared.35 In  all  the  cases,  a  bilateral  mid-
xillary  approach  was  used;  in  2,  preoperatively,35,36 and
n  2,  postoperatively.34,37 Grifﬁths  et  al.,34 in  a  heteroge-
eous  group  of  patients  that  underwent  oncogynecological
rocedures  by  mid-laparotomy,  did  not  ﬁnd  differences  in
he  consumption  of  opioids  in  the  ﬁrst  24  h  (34  mg  vs.
6.1  mg;  p  =  0.76),  in  the  early  EVA  at  rest  or  in  move-
ent  or  in  the  reduction  of  PONV.  De  Oliveira  et  al.36
ompared  the  use  of  TAP  with  ropivacaine  0.5%  vs.  ropi-
acaine  0.25%  and  placebo  TAP  in  outpatient  laparoscopic
rocedures,  demonstrating  that  TAP  improves  the  QoR-40
atisfaction  score  (average  16  ropivacaine  0.5%,  and  17
opivacaine  0.25%  vs.  saline;  p  <  0.05,  mainly  due  to  the
omponent  of  pain  and  the  consumption  of  opioids)  and
ound  no  differences  between  ropivacaine  0.5%  vs.  ropiva-
aine  0.25%.  The  apparition  of  secondary  effects  of  opioids
as  not  evaluated,  although  there  were  no  differences  in
he  quantity  of  antiemetics  used  in  the  3  groups  com-
ared.  Atim  et  al.35 demonstrated  lower  VAS  at  rest  or  in
arly  or  late  movement  in  total  abdominal  hysterectomy
ith  Pfannenstiel  incision  (p  <  0.0001),  the  TAP  and  inﬁltra-
ion  being  higher  than  the  inﬁltration  with  LA  (p  < 0.001).
he  consumption  of  opioids  was  signiﬁcantly  lower  in  the
AP  group  in  the  ﬁrst  4  h  (p  <  0.001).  There  was  no  reduc-
ion  in  the  secondary  effects  in  the  control  group  or  in
he  group  with  LA  inﬁltration.  However,  Kane  et  al.37 did
ot  ﬁnd  differences  in  the  consumption  of  opioids  in  the
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secondary  effects,  differently  from  the  other  RCTs20,22,23,27
where  the  TAP  did  not  have  good  results,  probably  due  to76  
oR-40  score  in  patients  that  underwent  laparoscopic  hys-
erectomy.
The  use  of  ultrasound-guided  TAP  in  inguinal  hernior-
haphy  with  general  anesthesia  was  studied  in  3  RCT38--40;
n  the  3  it  was  performed  in  unilateral,  mid-axillary,  and
reoperative.  Aveline  et  al.38 compared  TAP  vs.  ilioin-
uinal/iliohypogastric  block  demonstrating,  within  a  large
eries  of  275  patients,  that  the  TAP  decreased  the  pain
core  at  early  (average  11  vs.  15;  p  =  0.04)  and  late  (aver-
ge  29  vs.  33;  p  =  0.013)  rest,  and  the  mean  consumption  of
pioids  in  the  ﬁrst  24  h  (p  =  0.03).  Recently  López-González
t  al.39 compared  TAP  vs.  LA  local  inﬁltration  ﬁnding  no  sig-
iﬁcant  differences  in  VAS  pain  score  at  rest  or  in  movement.
lthough  the  mean  consumption  of  opioids  decreased  in  the
rst  24  h  (0.3  mg  vs.  1.05  mg;  p  <  0.05),  even  without  clinical
elevance,  the  difference  is  lower  and  there  were  no  differ-
nces  in  the  secondary  effects  of  opioids.  Petersen  et  al.40
ompare  the  use  of  TAP  vs.  placebo  TAP  and  vs.  ilioinguinal
lock  attended  by  a  surgeon  for  the  inﬁltration  of  surgical
ound,  demonstrating  that  the  execution  of  TAP  in  inguinal
erniorrhaphy  brings  no  beneﬁts  to  the  analgesia  obtained
rom  paracetamol  and  ibuprofen.
Niraj  et  al.41 demonstrated  that  the  TAPs  diminish  the
ean  consumption  of  opioids  in  the  ﬁrst  24  h  (28  mg  vs.
0  mg;  p  < 0.002),  the  VAS  at  rest  or  in  movement  in  the  ﬁrst
4  h  and  PONV  when  it  is  compared  to  intravenous  analgesia
n  patients  that  underwent  open  appendectomy,  and  have
ot  found  complications  associated  with  the  TAP.41
Two  RCTs  compared  TAP  vs.  placebo  in  donor
ephrectomy.42,43 In  both  RCTs  a  lower  mean  consumption
f  opioids  in  the  ﬁrst  24  h  (12.4  mg  vs.  21.6  mg;  p  =  0.015  in
he  ﬁrst  6  h42 and  103.8  ±  32.18  mg  vs.  235.8  ±  47.5  mg  in
he  ﬁrst  24  h)43 as  well  as  a  lower  postoperative  VAS  was
emonstrated.  In  none  there  were  differences  in  PONV,
edation  or  itching.
The  ultrasound-guided  TAP  in  laparoscopic  bariatric
urgery  was  evaluated  in  2  RCTs.44,45 Sinha  et  al.44 demon-
trated  the  utility  of  bilateral  TAP  vs.  placebo  by  using  a
odiﬁcation  of  the  classical  mid-axillary  approach  in  the
eduction  of  opioids  consumption  in  the  ﬁrst  24  h  (8  mg
s.  48  mg;  p  =  0.000),  and  in  VAS  at  rest  or  movement  in
he  ﬁrst  24  h,  as  well  as  all  for  the  secondary  effects
f  opioids.  However,  Albrecht  et  al.45,  comparing  TAP  vs.
o  TAP  in  patients  receiving  LA  inﬁltration,  did  not  ﬁnd
ny  beneﬁts  in  the  execution  of  TAP  by  oblique  subcostal
pproach.
Wu  et  al.46 compared  the  preoperative  oblique  subcostal
ilateral  TAP  in  radical  gastrectomy  to  thoracic  epidural
nd  no  intervention  (general  anesthesia),  ﬁnding  that  TAP
s  superior  to  the  general  anesthesia  for  the  consumption
f  opioids  in  the  ﬁrst  24  h,  but  inferior  to  thoracic  epidural
n  this  consumption.  TAP  did  not  diminish  VAS  in  compari-
on  to  general  anesthesia,  as  well  as  the  epidural  did  not
iminish  VAS  in  comparison  to  the  TAP.  Wu  et  al.46 conclude
hat  the  epidural  is  superior  to  the  TAP  in  radical  gastrec-
omy.
Recently,  the  bilateral  mid-axillary  TAP7 in  retropu-
ic  radical  prostatectomy  has  been  used,  demonstrating  a
iminution  in  the  consumption  of  opioids  in  the  ﬁrst  24  h
22.1  mg  vs.  45.5  mg;  p  <  0.05),  as  well  as  an  increase  in  the
ime  until  the  ﬁrst  opioid  rescue  (p  =  0.001)  and  a  lower  early
nd  late  pain  score  (p  <  0.05).
t
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pproach  and  time  for  block  execution
wenty-eight  RCTs  were  found  where  mid-axillary  approach
as  carried  out,18--44,47 one  subcostal,17 and  2  RCTs  in  which
he  oblique  subcostal  approach  was  executed.44,46
The  blockade  was  carried  out  preoperatively
n  15,18,21,28--32,34,35,37,38,40,43,44 and  postoperatively  in
617,19,20,22--27,34,37,40--43,47; obtaining  favorable  results  in  11  of
he  15  RCTs  carried  out  preoperatively,18,21,29--31,33,35,36,38,39,42
nd  in  11  of  the  16  RCTs  in  those  carried  out
ostoperatively.19,24--27,40--43,47 However,  none  of  the  RCTs
ompared  the  preoperative  vs.  postoperative  TAP  or
ifferent  approaches  for  the  same  intervention.
rugs,  volume  and  doses
everal  LAs  and  their  concentrations  were  used  in  TAP:  bupi-
acaine  in  10  (0.25%  in  421,30,35,39;  0.375%  in  217,43;  and  5%  in
26,29,30 and  1  mg  kg−1 in  one33) levobupivacaine  in  5  (0.25%  in
ne24; 0.375%  in  one22; 0.5%  in  228,38 and  2  mg  kg−1 in  one)18;
nd  ropivacaine  in  15  (0.25%  in  236,45;  0.375%  in  620,25,42--46;
.5%  in  520,36,37,39--41;  0.75%  in  one28; and  1  mg  kg−1 in  one23).
drenaline  was  added  in  3,22,37,45 and  clonidine  in  one.25 Only
n  2  there  was  a  comparison  for  different  concentrations
f  LA.30,36 In  none  of  them  the  use  of  different  volumes  or
ifferent  LA  for  the  same  intervention  were  compared.
ensitive  level,  duration  of  the  block  and
omplications
one  of  the  RCTs  reviewed  analyzed  the  sensitive  level  of
he  block  or  its  duration.  In  none  of  the  cases  complications
ere  reported.17--47
iscussion
he  execution  of  the  ultrasound-guided  TAP  in  colorec-
al  surgery  demonstrated  its  usefulness  for  surgeries  with
nfraumbilical  incision  by  mid-axillary  approach.18 Mean-
hile,  in  surgery  with  supraumbilical  incision,  despite
educing  the  consumption  of  opioids  in  the  ﬁrst  24  h,  it  did
ot  show  the  same  performance  signiﬁcantly  by  mid-axillary
pproach  when  compared  to  placebo,18 or  by  subcostal
pproach  when  it  is  compared  to  epidural  anesthesia.17 The
pidural  anesthesia  will  continue  to  be  the  ‘‘gold  standard’’
r  technique  of  election  for  this  intervention  until  more
vidence  with  TAP  is  available.
The  ITM  used  in  cesarean  provides  better  analgesia  than
he  TAP  at  the  expense  of  higher  adverse  effects.20,22,23 The
se  of  TAP  may  be  a  good  option  for  a  regime  of  multimodal
nalgesia,  since  it  reduces  the  VAS  score  at  rest  or  in  move-
ent  in  the  ﬁrst  24  h,  and  the  itching  and  PONV  in  those
ases  in  which  intrathecal  morphine  is  not  used.  Cánovas
t  al.27 demonstrated  that  the  TAP  improved  the  efﬁcacy  of
ntrathecal  opioids  reducing  the  pain  in  the  ﬁrst  24  h  of  the
ostoperative  period,  the  consumption  of  opiates  and  thehe  LA  used  (levobupivacaine  0.5%  20  ml  vs.  lower  concen-
rations  in  other  RCTs  with  ITM20,22,23) and  the  characteristics
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of  the  levobupivacaine.  In  the  RCTs  carried  out  by  Canovas
et  al.27 complications  related  to  the  TAP  were  not  reported,
although  it  is  important  to  remember  that  gestation  brings  a
higher  vascularization  that  increases  the  risk  to  reach  toxic
concentrations  of  LA,52 and  the  possibility  of  transference  of
the  LA  to  the  breast  milk  has  to  be  taken  into  account.53,54
In  case  of  cesarean  with  spinal  anesthesia  without  ITM
the  execution  of  the  TAP  demonstrated  up  to  60%  of  reduc-
tion  in  the  consumption  of  opioids.21 However,  a  lower  VAS
or  PONV,  itching  or  sedation  was  not  obtained,  thereby  the
execution  of  the  TAP  could  be  indicated  for  those  cases  of
hypersensitivity  to  opioid,  history  of  PONV,  or  possibility  of
transference  of  opiate  to  breast  milk.55 In  case  of  cesarean
with  general  anesthesia,  the  execution  of  the  bilateral  TAP
demonstrates  reduction  in  the  consumption  of  opioids24,26;
although  the  reduction  in  VAS  is  not  conclusive,  it  improved
in  one  RCT,24 and  no  differences  were  found  in  another26;  it
equally  occurs  with  the  apparition  of  secondary  effects  of
opioids.  In  the  RCT  executed  by  Tan  et  al.24 levobupivacaine
0.25%  was  used,  and  in  that  carried  out  by  Eslamian  et  al.,26
bupivacaine  at  0.25%.
The  execution  of  bilateral  TAP  is  a  valid  alternative
in  patients  undergoing  cesarean  without  ITM,  since  it
decreases  the  consumption  of  opioids  and  their  secondary
effects.  These  conclusions  are  not  similar  to  those  obtained
in  recent  meta-analysis  where  ultrasound-guided  TAP  is  not
speciﬁed.52,56 However,  in  those  cesareans  in  which  spinal
anesthesia  with  ITM  is  carried  out,  it  did  not  demonstrate
to  be  beneﬁcial,40 considering  the  scarce  clinical  relevance
of  pain  reduction  only  within  the  ﬁrst  2  postoperative
hours.
The  execution  of  bilateral  mid-axillary  TAP  for  laparo-
scopic  cholecystectomy  demonstrated  that  it  reduces  the
postoperative  consumption  of  opioids,30,31 the  intraoper-
ative  consumption  of  opioids30,31 and  VAS30--33 when  it  is
compared  to  placebo  TAP  or  no  intervention.  However,  com-
pared  with  LA  inﬁltration,  it  obtains  just  the  decreasing
of  the  consumption  of  opioids  and  VAS  when  a  subcostal
approach  is  performed.32,33 Ra  et  al.30 demonstrated  that
in  the  execution  of  TAP  there  are  no  differences  with
bupivacaine  0.25%  or  bupivacaine  0.5%.  The  inﬁltration  of
laparoscopic  wounds  after  cholecystectomy  is  an  habitual
practice,  although  it  had  good  results  with  mid-axillary
TAP  when  TAP  vs.  placebo  TAP  or  no  intervention  are
compared.29--31 When  it  is  compared  to  LA  inﬁltration,  results
are  not  obtained,32 so  that  the  execution  of  TAP  may  be  a
valid  option  in  case  of  impossibility  of  local  LA  inﬁltration,
or  as  a  way  of  reducing  the  consumption  of  intraoperative
analgesics.  With  the  subcostal  approach,  the  VAS  and  the
consumption  of  opioids  are  improved,33 so  that  in  case  of
execution  of  TAP  in  cholecystectomy,  this  approach  should
be  elected.  More  RCTs  are  required  in  order  to  determine
the  optimal  dose  and  volume  in  this  intervention.
The  studies  carried  out  in  gynecological  procedures  are
very  heterogeneous.  The  execution  of  preoperative  mid-
axillary  TAP  demonstrated  to  be  useful  and  superior  to
the  local  LA  inﬁltration  in  total  abdominal  hysterectomy
with  Pfannenstiel  incision35 and  in  outpatient  gynecological
procedures,36 despite  not  having  demonstrated  to  be  effec-
tive  in  laparoscopic  hysterectomy37 or  in  a  heterogeneous
group  of  procedures  with  mid-laparotomy.34 Given  the  het-
erogeneity  of  the  RCTs  in  the  gynecological  interventions,
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ew  RCTs  are  needed,  even  though  it  has  been  demonstrated
o  be  effective  in  total  abdominal  hysterectomy.35
The  execution  of  TAP  in  inguinal  herniorrhaphy  is
ontradictory,38--40 since  that,  although  Aveline  et  al.38
ave  demonstrated  it  was  superior  to  the  ilioin-
uinal/iliohypogastric  block  when  compared  to  placebo,  no
eneﬁts  in  the  diminution  in  the  pain  score  are  found.40
here  is  a  grade  of  evidence  IA,  recommendation  A  for  the
xecution  of  blocks  of  abdominal  wall/local  LA  inﬁltration
or  inguinal  herniorrhaphy.57 Due  to  the  scarse  clinical  rele-
ance  that  it  demonstrated  when  compared  to  the  local  LA
nﬁltration,39,40 currently  it  is  not  permitted  to  recommend
ts  use  for  the  intervention,  the  local  LA  inﬁltration  being  a
echnique  of  choice.
The  mid-axillary  TAP  demonstrated  to  be  useful  when
ompared  to  placebo  in  patients  undergoing  laparo-
copic  bariatric  surgery  where  local  LA  inﬁltration  is  not
xecuted44.  However,  it  is  not  the  same  for  patients
ho  receive  inﬁltration  of  laparoscopic  wounds45 although
romising  oblique  subcostal  approach  is  used8,14 that  could
e  due  to  the  preincisional  execution  of  block  in  a  full-length
ntervention,  or  to  the  lack  of  beneﬁt  for  the  addition  of  TAP
o  the  local  LA  inﬁltration.  The  results  of  the  TAP,  when  they
re  compared  to  the  inﬁltration  with  LA,  are  not  conclusive,
emonstrating  to  be  superior  in  some  RCTs33,35,39 and  not  in
thers32 and  having  similar  results  to  those  of  Albrecht  et
l45 when  TAP  vs.  no  TAP  is  compared  in  patients  that  receive
ocal  LA  inﬁltration.58
The  unilateral  mid-axillary  TAP  demonstrated  to  provide
ppropriate  analgesia  in  patients  submitted  to  open
ppendectomy.40
Recently,  Hosgood  et  al.42 and  Parikh  et  al.43 demon-
trated  the  efﬁcacy  of  the  mid-axillary  TAP  in  donor
ephrectomy.  Wu  et  al.46 conclude  that  the  epidural  tech-
ique  is  superior  to  a  single-dose  TAP  via  oblique  subcostal
n  radical  gastrectomy;  however,  probably  the  use  of
atheters  in  TAP  would  improve  the  results,  as  Niraj  et  al.17
uggest  and  in  studies  carried  out  in  renal  and  hepato-
iliary  surgery,  not  ﬁnding  differences  between  TAP  with
atheter  and  epidural  anesthesia.  Trials  carried  out  with  TAP
ttended  by  surgeon,  in  supraumbilical  colorectal  surgery9
nd  ultrasound-guided18, demonstrated  its  efﬁcacy  so  that
he  debate  about  the  appropriate  approach  for  each  inter-
ention  still  remains,  and  the  TAP  could  be  a  useful  option  if
ts  efﬁcacy  was  demonstrated  in  these  interventions,  mainly
hose  in  programs  of  accelerated  recovery  where  epidu-
al  anesthesia,  considered  as  the  ‘‘gold  standard’’  for  this
ntervention,  is  avoided.17
Due  to  the  fact  that  only  in  retropubic  radical  prosta-
ectomy  the  TAP  was  evaluated,47 despite  the  good  results
btained,  more  RCTs  are  needed  in  order  to  conﬁrm  these
esults  and  their  clinical  beneﬁts.
imitations
he  bibliographic  research  was  limited  to  MEDLINE-Pubmed
nd  to  a  manual  driven  one,  aiming  to  comprise  all  the
CTs  published,  so  that  there  may  be  published  RCTs  not
valuated.
The  authors  limited  the  research  and  the  analysis  to
CT  that  evaluated  the  ultrasound-guided  TAP  because  of
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278  
he  decrease  of  complications  and  the  greater  variety  of
pproaches  that  the  ultrasound-guided  technique  permits,
lthough  the  multiple  RCTs  executed  with  attended  TAP  or
AP  based  on  references  should  be  equally  considered  by  the
nterest  to  the  technique.
onclusions
he  execution  of  bilateral  mid-axillary  TAP  is  indicated
n  patients  undergoing  cesarean  without  ITM19--21,24--26; in
holecystectomy  by  subcostal  TAP,33 or  mid-axillary  where
he  inﬁltration  is  impossible,  or  as  a  way  of  reducing  the
onsumption  of  postoperative  opioids;  in  total  abdomi-
al  hysterectomy  by  bilateral  mid-axillary  TAP35; in  open
ppendectomy  by  unilateral  mid-axillary  TAP40;  in  donor
ephrectomy,  mid-axillary  TAP.42,43 However,  there  are  con-
roversies  in  the  use  of  oblique  subcostal  TAP  in  radical
astrectomy,17,46 in  the  use  of  bilateral  mid-axillary  in  colo-
ectal  surgery18 and  in  retropubic  radical  prostatectomy,47
ecause  of  the  limitation  of  the  RCT  analyzed.
It  is  not  possible  to  recommend  its  use  in  inguinal
erniorrhaphy.40
There  is  a  considerable  debate  about  the  best  approach
or  each  type  of  intervention59 since  that  despite  the  demon-
tration  of  metameric  extension  described  by  Lee  et  al.14
nd  Carney  et  al.,15 the  data  found  in  RCT  are  not  conclu-
ive  or  concordant.  New  well-designed  RCTs  with  enough
tatistical  power  to  solve  the  current  questions  and  their
onsequences  in  the  habitual  clinical  practice  are  required.
he  lack  of  RCTs  that  compare  the  pre-  or  postoperative
xecution  of  TAP  in  the  same  surgical  intervention  ren-
ers  it  impossible  to  recommend  the  appropriate  time  to
he  execution  of  the  block.  In  comparing  TAP  with  differ-
nt  concentrations,30,36 it  was  demonstrated  that  there  are
o  beneﬁts  in  using  a  higher  dose,  and  given  the  potential
oxic  effects  of  LA  in  the  TAP  and  the  possible  overcom-
ng  of  their  toxic  dose,  as  demonstrated  by  Grifﬁths  et  al.60
ith  doses  of  ropivacaine  habitually  used,  it  is  necessary  to
tudy  the  effective  minimum  doses  to  decrease  the  possible
eleterious  effects  of  the  LA.
The  use  of  catheters  in  the  abdominal  transverse  plan
ould  increase  the  analgesic  efﬁcacy  of  the  block,  as  well
s  the  use  of  new  LA,  like  the  recently  approved  liposomal
upivacaine  (EXPAREL),  which  could  increase  the  duration
f  the  block,  although  there  are  no  trials  about  the  safety
f  this  new  drug  in  peripheral  blocks.  Ultimately,  in  the  exe-
ution  of  new  RCTs  it  would  be  convenient  to  determine  the
ensitive  level  of  the  block,  as  well  as  its  duration  and  the
lasmatic  concentrations  reached  with  different  concentra-
ions  and  volumes  of  LA,  in  order  to  determine  the  optimal
ose  of  LA  for  each  intervention.
onﬂicts of interest
he  authors  declare  no  conﬂicts  of  interest.
cknowledgementshe  authors  would  like  to  acknowledge  the  staff  of  the  Pro-
essional  Library  of  Hospital  Universitario  Infanta  Leonor
adrid  for  the  inestimable  collaboration.J.  Ripollés  et  al.
eferences
1. Raﬁ AN. Abdominal ﬁeld block: a new approach via the lumbar
triangle. Anaesthesia. 2011;56:1024--6.
2. Hebbard P, Fujiwara Y, Shibata Y, et al. Ultrasound-guided
transversus abdominis plane (TAP) block. Anaesth Intensive
Care. 2007;35:616--7.
3. Kearns RJ, Young SJ. Transversus abdominis plane blocks; a
national survey of techniques used by UK obstetric anaes-
thetists. Int J Obstet Anesth. 2011;20:103--4.
4. McDermott G, Korba E, Mata U, et al. Should we stop
doing blind transversus abdominis plane blocks? Br J Anaesth.
2012;108:499--502.
5. Jankovic Z, Ahmad N, Ravishankar N, et al. Transversus abdo-
minis plane block: how safe is it? Anesth Analg. 2012;107:
1758--9.
6. Farooq M, Carey M. A case of liver trauma with a blunt
regional anesthesia needle while performing transversus abdo-
minis plane block. Reg Anesth Pain Med. 2008;33:274--5.
7. Blanco R. TAP block under ultrasound guidance: the descrip-
tion of a «no pops trechnique».  Reg Anaesth Pain Med. 2007;32
Suppl. 1:130.
8. Hebbard P. Subcostal transversus abdominis plane block
under ultrasound guidance. Anesth Analg. 2008;106:674--7675.
Réplica 675.
9. Borglum J, Maschmann C, Belhage B, et al. Ultrasound-guided
bilateral dual transversus abdominis plane block: a new four-
point approach. Acta Anaesthesiol Scand. 2011;55:658--63.
0. Neal JM, Brull R, Chan VWS, et al. The ASRA evidence-based
medicine assessment of ultrasound-guided regional anesthesia
and pain medicine: executive summary. Reg Anesth Pain Med.
2010;35 2 Suppl.:S1--9.
1. Abrahams MS, Horn J-L, Noles LM. Evidence-based medicine:
ultrasound guidance for truncal blocks. Reg Anesth Pain Med.
2010;35 2 Suppl.:S36--42.
2. McDonnell JG, O’Donnell BD, Farrell T, et al. Transversus abdo-
minis plane block: a cadaveric and radiological evaluation. Reg
Anesth Pain Med. 2007;32:399--404.
3. Tran TMN, Ivanusic JJ, Hebbard P. Determination of spread of
injectate after ultrasound-guided transversus abdominis plane
block: a cadaveric study. Br J Anaesth. 2009;102:123--7.
4. Lee THW, Barrington MJ, Tran TMN. Comparison of extent of
sensory block following posterior and subcostal approaches to
ultrasound-guided transversus abdominis plane block. Anaesth
Intensive Care. 2010;38:452--60.
5. Carney J, Finnerty O, Rauf J, et al. Studies on the spread
of local anaesthetic solution in transversus abdominis plane
blocks. Anaesthesia. 2011;66:1023--30.
6. McDonnell JG, Finnerty O, Laffey JG. Stellate ganglion block-
ade for analgesia following upper limb surgery. Anaesthesia.
2011;66:611--4.
7. Niraj G, Kelkar A, Jeyapalan I, et al. Comparison of analgesic
efﬁcacy of subcostal transversus abdominis plane blocks with
epidural analgesia following upper abdominal surgery. Anaes-
thesia. 2011;66:465--71.
8. Walter CJ, Maxwell-Armstrong C, Pinkney TD, et al. A ran-
domised controlled trial of the efﬁcacy of ultrasound-guided
transversus abdominis plane (TAP) block in laparoscopic colo-
rectal surgery. Surg Endosc. 2013;27:2366--72.
9. Belavy D, Cowlishaw PJ, Howes M, et al. Ultrasound-guided
transversus abdominis plane block for analgesia after Caesarean
delivery. Br J Anaesth. 2009;103:726--30.
0. Costello JF, Moore AR, Wieczorek PM, et al. The transversus
abdominis plane block, when used as part of a multimodal
regimen inclusive of intrathecal morphine, does not improve
analgesia after cesarean delivery. Reg Anesth Pain Med.
2009;34:586--9.
ckad
3
3
4
4
4
4
4
4
4
4
4
4
5
5
5
5
5Efﬁcacy  of  ultrasound-guided  transverse  abdominal  plan  blo
21. Baaj JM, Alsatli RA, Majaj HA, et al. Efﬁcacy of ultrasound-
guided transversus abdominis plane (TAP) block for postce-
sarean section delivery analgesia -- a double-blind, placebo-
controlled, randomized study. Middle East J Anesthesiol.
2010;20:821--6.
22. Kanazi GE, Aouad MT, Abdallah FW, et al. The anal-
gesic efﬁcacy of subarachnoid morphine in comparison with
ultrasound-guided transversus abdominis plane block after
cesarean delivery: a randomized controlled trial. Anesth Analg.
2010;111:475--81.
23. Loane H, Preston R, Douglas MJ, et al. A randomized controlled
trial comparing intrathecal morphine with transversus abdomi-
nis plane block for post-cesarean delivery analgesia. Int J Obstet
Anesth. 2012;21:112--8.
24. Tan TT, Teoh WHL, Woo DCM, et al. A randomised trial of the
analgesic efﬁcacy of ultrasound-guided transversus abdominis
plane block after caesarean delivery under general anaesthesia.
Eur J Anaesthesiol. 2012;29:88--94.
25. Bollag L, Richebe P, Siaulys M, et al. Effect of transversus abdo-
minis plane block with and without clonidine on post-cesarean
delivery wound hyperalgesia and pain. Reg Anesth Pain Med.
2012;37:508--14.
26. Eslamian L, Jalili Z, Jamal A, et al. Transversus abdominis
plane block reduces postoperative pain intensity and analgesic
consumption in elective cesarean delivery under general anes-
thesia. J Anesth. 2012;26:334--8.
27. Cánovas L, López C, Castro M, et al. Contribution to post-
caesarean analgesia of ultrasound-guided transversus abdominis
plane block. Rev Esp Anestesiol Reanim. 2013;60:124--8.
28. Lee AJ, Palte HD, Chehade JMA, et al. Ultrasound-guided bilat-
eral transversus abdominis plane blocks in conjunction with
intrathecal morphine for postcesarean analgesia. J Clin Anesth.
2013;25:475--82.
29. El-Dawlatly AA, Turkistani A, Kettner SC, et al. Ultrasound-
guided transversus abdominis plane block: description of a
new technique and comparison with conventional systemic
analgesia during laparoscopic cholecystectomy. Br J Anaesth.
2009;102:763--7.
30. Ra YS, Kim CH, Lee GY. The analgesic effect of the ultrasound-
guided transverse abdominis plane block after laparoscopic
cholecystectomy. Korean J Anesthesiol. 2010;58:362--8.
31. Petersen PL, Stjernholm P, Kristiansen VB, et al. The beneﬁcial
effect of transversus abdominis plane block after laparoscopic
cholecystectomy in day-case surgery: a randomized clinical
trial. Anesth Analg. 2012;115:527--33.
32. Ortiz J, Suliburk JW, Wu K, et al. Bilateral transversus abdo-
minis plane block does not decrease postoperative pain after
laparoscopic cholecystectomy when compared with local anes-
thetic inﬁltration of trocar insertion sites. Reg Anesth Pain Med.
2012;37:188--92.
33. Tolchard S, Martindale S, Davies R. Efﬁcacy of the subcostal
transversus abdominis plane block in laparoscopic cholecys-
tectomy: comparison with conventional port-site inﬁltration. J
Anaesthesiol Clin Pharmacol. 2012;28:339.
34. Grifﬁths JD, Middle JV, Barron FA, et al. Transversus abdominis
plane block does not provide additional beneﬁt to multi-
modal analgesia in gynecological cancer surgery. Anesth Analg.
2010;111:797--801.
35. Atim A, Bilgin F, Kilickaya O, et al. The efﬁcacy of ultrasound-
guided transversus abdominis plane block in patients undergoing
hysterectomy. Anaesth Intensive Care. 2011;39:630--4.
36. De Oliveira GS Jr, Fitzgerald PC, Marcus R-J, et al. A dose-
ranging study of the effect of transversus abdominis block on
postoperative quality of recovery and analgesia after outpatient
laparoscopy. Anesth Analg. 2011;113:1218--25.
37. Kane SM, Garcia-Tomas V, Alejandro-Rodriguez M, et al. Ran-
domized trial of transversus abdominis plane block at total
5e  279
laparoscopic hysterectomy: effect of regional analgesia on qual-
ity of recovery. Am J Obstet Gynecol. 2012;207:419, e1--5.
8. Aveline C, le Hetet H, le Roux A, et al. Comparison between
ultrasound-guided transversus abdominis plane and conven-
tional ilioinguinal/iliohypogastric nerve blocks for day-case
open inguinal hernia repair. Br J Anaesth. 2011;106:380--6.
9. López González JM, Jiménez Gómez BM, Areán González I,
et al. Bloqueo transverso abdominal ecoguiado vs. inﬁltración
de herida quirúrgica en cirugía ambulatoria de hernia inguinal.
Cir May Amb. 2013;18:7--11.
0. Petersen PL, Mathiesen O, Stjernholm P, et al. The effect of
transversus abdominis plane block or local anaesthetic inﬁltra-
tion in inguinal hernia repair: a randomised clinical trial. Eur J
Anaesthesiol. 2013;30:415--21.
1. Niraj G, Searle A, Mathews M, et al. Analgesic efﬁcacy
of ultrasound-guided transversus abdominis plane block in
patients undergoing open appendicectomy. Br J Anaesth.
2009;103:601--5.
2. Hosgood SA, Thiyagarajan UM, Nicholson HFL, et al. Random-
ized clinical trial of transversus abdominis plane block versus
placebo control in live-donor nephrectomy. Transplantation.
2012;94:520--5.
3. Parikh BK, Waghmare VT, Shah VR, et al. The analgesic efﬁ-
cacy of ultrasound-guided transversus abdominis plane block for
retroperitoneoscopic donor nephrectomy: a randomized con-
trolled study. Saudi J Anaesth. 2013;7:43--7.
4. Sinha A, Jayaraman L, Punhani D. Efﬁcacy of ultrasound-guided
transversus abdominis plane block after laparoscopic bariatric
surgery: a double blind, randomized, controlled study. Obes
Surg. 2013;23:548--53.
5. Albrecht E, Kirkham KR, Endersby RVW, et al. Ultrasound-
guided transversus abdominis plane (TAP) block for laparoscopic
gastric-bypass surgery: a prospective randomized controlled
double-blinded trial. Obes Surg. 2013;23:1309--14.
6. Wu  Y, Liu F, Tang H, et al. The analgesic efﬁcacy of subcostal
transversus abdominis plane block compared with thoracic
epidural analgesia and intravenous opioid analgesia after radi-
cal gastrectomy. Anesth Analg. 2013;17:507--13.
7. Elkassabany N, Ahmed M, Malkowicz SB, et al. Comparison
between the analgesic efﬁcacy of transversus abdominis plane
(TAP) block and placebo in open retropubic radical prostatec-
tomy: a prospective, randomized, double-blinded study. J Clin
Anesth. 2013;25:459--65.
8. Milan ZB, Duncan B, Rewari V, et al. Subcostal transversus abdo-
minis plane block for postoperative analgesia in liver transplant
recipients. Transplant Proc. 2011;43:2687--90.
9. Skjelsager A, Ruhnau B, Kistorp TK, et al. Transversus abdomi-
nis plane block or subcutaneous wound inﬁltration after open
radical prostatectomy: a randomized study. Acta Anaesthesiol
Scand. 2013;57:502--8.
0. Urrútia G, Bonﬁll X. PRISMA declaration: a proposal to improve
the publication of systematic reviews and meta-analyses. Med
Clin (Barc). 2010;135:507--11.
1. Petersen PL, Mathiesen O, Torup H, et al. The transversus
abdominis plane block: a valuable option for postopera-
tive analgesia? A topical review. Acta Anaesthesiol Scand.
2010;54:529--35.
2. Sharkey A, Finnerty O, McDonnell JG. Role of transversus
abdominis plane block after caesarean delivery. Curr Opin
Anaesthesiol. 2013;26:268--72.
3. Zeisler JA, Gaarder TD, de Mesquita SA. Lidocaine excretion in
breast milk. Drug Intell Clin Pharm. 1986;20:691--3.
4. Ito S, Lee A. Drug excretion into breast milk -- overview. Adv
Drug Deliv Rev. 2003;55:617--27.5. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality
of reports of randomized clinical trials: is blinding necessary?
Control Clin Trials. 1996;17:1--12.
25
5
5
5
block. Reg Anesth Pain Med. 2012;37:193--209.
60. Grifﬁths JD, Barron FA, Grant S, et al. Plasma ropivacaine80  
6. Mishriky BM, George RB, Habib AS. Transversus abdominis plane
block for analgesia after cesarean delivery: a systematic review
and meta-analysis. Can J Anaesth. 2012;59:766--78.
7. Nordin P, Zetterstrom H, Carlsson P, et al. Cost-effectiveness
analysis of local, regional and general anaesthesia for inguinal
hernia repair using data from a randomized clinical trial. Br J
Surg. 2007;94:500--5.
8. Brady RR, Ventham NT, Roberts DM, et al. Open transver-
sus abdominis plane block and analgesic requirements inJ.  Ripollés  et  al.
patients following right hemicolectomy. Ann R Coll Surg Engl.
2012;94:327--30.
9. Abdallah FW, Chan VW, Brull R. Transversus abdominis planeconcentrations after ultrasound-guided transversus abdominis
plane block. Br J Anaesth. 2010;105:853--6.
